These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22000978)

  • 1. Response: myeloperoxidase as a biomarker in acute coronary syndrome: a trap or a treasure.
    Chen Y; Zhang F; Dong L; Shu X
    Arch Med Res; 2011 Oct; 42(7):642-3. PubMed ID: 22000978
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloperoxidase as a biomarker in acute coronary syndrome: beware of the pitfalls.
    Lee R
    Arch Med Res; 2011 Oct; 42(7):641. PubMed ID: 22000979
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myeloperoxidase as possible diagnostic and prognostic marker of acute coronary syndrome].
    Gustapane M; Cardillo MT; Biasillo G; Biasucci LM
    Recenti Prog Med; 2011 Nov; 102(11):447-50. PubMed ID: 22120783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Schindhelm regarding article, "High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study".
    Schindhelm RK
    Circulation; 2011 Jul; 124(4):e143; author reply e144. PubMed ID: 21788597
    [No Abstract]   [Full Text] [Related]  

  • 5. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
    Ferrante G; Nakano M; Prati F; Niccoli G; Mallus MT; Ramazzotti V; Montone RA; Kolodgie FD; Virmani R; Crea F
    Circulation; 2010 Dec; 122(24):2505-13. PubMed ID: 21126969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome].
    Li L; Zhang Y; Chen YG; Li GS; Wang Y; Ma X; Li JF; Zhong M; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1106-8. PubMed ID: 16563281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase is not useful for the early assessment of patients with chest pain.
    Eggers KM; Dellborg M; Johnston N; Oldgren J; Swahn E; Venge P; Lindahl B
    Clin Biochem; 2010 Feb; 43(3):240-5. PubMed ID: 19822136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean platelet volume: a prognostic biomarker after percutaneous coronary interventıon.
    Ege MR
    Am J Cardiol; 2011 Apr; 107(8):1253. PubMed ID: 21457811
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
    Sawicki M; Sypniewska G; Kozinski M; Gruszka M; Krintus M; Obonska K; Pilaczynska-Cemel M; Kubica J
    Eur J Clin Invest; 2011 Jun; 41(6):667-71. PubMed ID: 21226709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of biochemical marker detection in risk stratification in patients with acute coronary syndrome].
    Liu B; Fu Q; Yan QN; Jin W; Tao DP; Hua JH; Li ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1015-9. PubMed ID: 20501382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart fatty acid binding protein (H-FABP) as a diagnostic biomarker in patients with acute coronary syndrome.
    Gururajan P; Gurumurthy P; Nayar P; Srinivasa Nageswara Rao G; Babu S; Cherian KM
    Heart Lung Circ; 2010 Nov; 19(11):660-4. PubMed ID: 20674495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biomarkers--the long march from bench to bedside.
    Weber M; Hamm C
    Eur Heart J; 2008 May; 29(9):1079-81. PubMed ID: 18390873
    [No Abstract]   [Full Text] [Related]  

  • 14. Current role of myeloperoxidase in routine clinical practice.
    Dominguez-Rodriguez A; Abreu-Gonzalez P
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):223-30. PubMed ID: 21453218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of highly sensitive troponin in the evaluation of acute coronary syndrome.
    Mohammed AA; Januzzi JL
    Compr Ther; 2009; 35(3-4):167-76. PubMed ID: 20043613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved electrochemical immunosensor for myeloperoxidase in human serum based on nanogold/cerium dioxide-BMIMPF6/L-Cysteine composite film.
    Lu L; Liu B; Li S; Zhang W; Xie G
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):339-44. PubMed ID: 21561744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kominami G; Kita T
    J Cardiol; 2010 Sep; 56(2):159-65. PubMed ID: 20605699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraisal of myeloperoxidase for evaluation of patients with suspected acute coronary syndromes.
    Morrow DA
    J Am Coll Cardiol; 2007 May; 49(20):2001-2. PubMed ID: 17512354
    [No Abstract]   [Full Text] [Related]  

  • 19. Leptin in acute coronary syndromes: has the time come for its use in risk stratification?
    Amasyali B; Kose S; Kursaklioglu H; Kilic A; Isik E
    Int J Cardiol; 2008 Nov; 130(2):264-5. PubMed ID: 17669522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute coronary syndromes: to CRP or not to CRP?
    Biasucci LM; Liuzzo G; Crea F
    J Am Coll Cardiol; 2008 Oct; 52(18):1500; author reply 1500-1. PubMed ID: 19017520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.